This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Thats why auticon started the Auticon Training Institute (ATI), a US nonprofit offering structured IT and tech training pathways, certifications, internships, mentorships, and networking opportunities free of charge for autistic adults, empowering them to start careers in software engineering, data analysis, cybersecurity, and more.
Product and service innovation: Software companies now sell AI-driven analytics as products, automakers offer AI features (like driver assist or predictive maintenance) as differentiators and healthcare firms use AI to develop new diagnostics and personalized medicine. Crucially, the time and cost to implement AI have fallen.
But the University of Washington professor is surely itching to get back to his lab on campus in Seattle, where he works with students and fellow researchers on the future of protein design, a fast-moving field using state-of-the-art technology to develop new therapeutics, vaccines, biosensors, materials and more. AstraZeneca paid $1.1
Levitate Bio’s CEO Sam DeLuca, left, and Karen Khar, executive vice president of sales and business development. The foundation was created by RosettaCommons, a multi-institution coalition that built a software platform called Rosetta that is used for modeling biomolecular compounds.
Adaptive Photo) — Mark Adams is stepping down as chief operating officer of Adaptive Biotechnologies , the company said today in a regulatory filing. Rubinstein joined Adaptive in 2011 as senior vice president of corporate and business development and became president seven years later. Mark Adams.
Every business unit has a stake in the IT services, apps, networks, hardware, and software needed to meet business goals and objectives, and many of them are hiring their own technologists. Healthcare Technology is paramount for the healthcare industry, including the medical, pharmaceutical, and biotechnology industries.
Adaptive Biotechnologies , which develops technology to assess the immune response, posted $154.3 Progress on a collaboration with biopharma company Nykode Therapeutics to support the development of a T-cell based COVID-19 vaccine. Adaptive moved into its new headquarters in September. GeekWire Photo / Charlotte Schubert).
Using HPC from the University of Cambridge, researchers are creating a new method of machine learning whereby the computer ‘learns how to learn’—which could advance studies in drug development and disease treatment. A team from the UK, Sweden, India, and the Netherlands developed the approach, known as transformational machine learning (TML).
The news: Seattle-based protein engineering company Cyrus Biotechnology has raised $18 million and acquired Orthogonal Biologics , a spinout from the University of Illinois at Urbana Champaign, which is developing a COVID-19 therapeutic. Cyrus has proven the power of its Rosetta-based platform as a software and services company.
In a region better known for its tech startups and legions of software engineers, it’s biotech companies that have helped lead a recent IPO boom in the state of Washington, accounting for eight of 11 firms joining the public markets via a traditional IPO over the past year. based biotech company went public. Absci Photo).
That’s the case for Yi Zhou, CTO and CIO with Adaptive Biotechnologies. In today’s dynamic business environment, IT must transcend traditional roles,” Adaptive Biotechnologies’ Zhou says. He plans to scale his company’s experimental generative AI initiatives “and evolve into an AI-native enterprise” in 2024. He has a plan to do that.
Cyrus Biotechnology has several drug discovery and development partnerships and also sells Cyrus Bench, a software platform for protein engineering. Seattle-based Cyrus Biotechnology is entering a protein engineering collaboration with Boston-based Selecta Biosciences that could pull in up to $1.5 Cyrus Photo).
Chad Robins, left, is co-founder and CEO of Adaptive Biotechnologies, which he co-founded with his brother, Harlan Robins, right, a theoretical physicist turned computational biologist who is the company’s chief scientific officer. Adaptive Biotechnologies Photo).
Symbl CEO Surbhi Rathore said in a LinkedIn post that Senthivel “has been instrumental in developing foundational infrastructure that serves across industries.” software analytics company. ” Toshish Jawale , Symbl’s co-founder and former CTO, moved to the role of chief AI engineer. ” Ken Suzuki.
A protein structure generated by a machine learning algorithm developed by the University of Washington’s Institute for Protein Design. (UW New protein structures not seen in nature have emerged from deep learning software deployed by University of Washington researchers and their colleagues. UW IPD Photo | Ian C.
The category highlights pioneering health, life science, biotechnology or medical breakthroughs that hold great promise for bettering our lives or improving the healthcare system. Good Therapeutics Graphic) Developing therapeutics that are active only where they are needed in the body has the potential to reduce toxic side effects.
Founded in 2011, Athira is in late-stage development for its lead therapeutic candidate called NDX-1017. Formerly known as M3 Biotechnology, the company is led by Dr. That reflects the traditional life cycle of biotech companies, which commonly invest in research and development for years before bringing products to market.
Seattle-based Adaptive Biotechnologies announced Nitin Sood as its first-ever chief commercial officer. announced Jaisimha Muthegere as SVP of engineering, as well as the acquisition of project management software company Zepel.io. He was most recently CTO for San Francisco-based employee management software Reflektive.
The Seattle biotech filed initial IPO paperwork Wednesday, a surprising move that would give the company additional capital to develop its therapies for brain diseases. Founded in 2011, Athira is in late-stage development for its lead therapeutic candidate called NDX-1017. Five software startups filed for an IPO on Monday alone.
Absci, which partners with other biopharma companies to identify and develop protein-based drug candidates, has its roots in Portland. Things are different now, said Alexandre, as companies such as Seagen and Adaptive Biotechnologies go public and grow in the region. Bolstering the workforce, increasing regional connections.
Thielke is currently managing director of Hines Asia Pacific, a global real estate investment, development and management firms. Lockstep , a Seattle accounting software startup, has emerged from stealth mode. . Lockstep , a Seattle accounting software startup, has emerged from stealth mode. billion. . Moore has a Ph.D
And with the availability of a multitude of software solutions to remedy such issues as manufacturing, supply chain, finance, and procurement, the innovations derived from those applications are done by the people , transforming both industries and society. But can it, really? The answer is a definitive “No!”
“Her expertise of harmonizing hardware and softwaredevelopment in partnership with enterprise customers, and their engineering teams, will be a key component in our next phase of growth,” Johnson said of Trewin in a statement. Adaptive Biotechnologies’ fourth quarter revenue was up 25% from a year ago.
Tomorrow has developed technology that reduces water loss in produce with a patent-pending cooling system that can manage the atmosphere. The Seattle-based company, which developssoftware to assist salespeople, was valued at more than $4 billion valuation a few years ago. Andrew Kinzer. Kinzer left the company in 2020.
Workplace of the Year finalists, clockwise from top left: Adaptive Biotechnologies co-founders Harlan and Chad Robins; the Helion team; Impinj offices in Seattle; Treasury4 team; Blink CEO Karen Clark Cole. This year’s finalists are Adaptive Biotechnologies, Blink, Helion, Impinj and Treasury4. based healthcare software company.
Monod Bio is developing biosensors that can quickly detect viral proteins, toxins, antibodies, or other molecules. The sensors are built from engineered proteins developed at the IPD. Monod’s sensors are designed with protein engineering softwaredeveloped earlier at IPD, called Rosetta. Monod Photos).
That reflects the traditional life cycle of biotech companies, which commonly invest in research and development for years before bringing products to market. In its IPO filing, Grail said its multi-cancer early detection test, Galleri, will commercially launch in 2021 as a laboratory-developed test. Total funding is now north of $1.9
Clockwise, from top left: SEngine Precision CEO Carla Grandori; Joon Care CEO Emily Pesce; FlavorCloud CEO Rathna Sharad; AltPep CEO Valerie Daggett; and Strella Biotechnology CEO Katherine Sizov. GeekWire Photo / Kevin Lisota) Last year’s winner was Prem Kumar , CEO of Humanly, a Seattle-based recruiting software startup.
Jeff Bezos-backed startup Nautilus Biotechnology set to go public via SPAC at $900M valuation. Nautilus Biotechnology, a Seattle-based biotech startup led by Isilon co-founder Sujal Patel, is the latest company to go public using a special purpose acquisition company, or SPAC. Most popular stories on GeekWire. … Read More.
Adaptive Biotechnologies Corporation disclosed in a SEC filing that Leslie Trigg is voluntarily resigning from the company’s board. He previously worked as VP of platform engineering at Paris-based carpooling platform BlaBlaCar and was an engineer at Chef Software. It acquired Adaptive Technology Group in 2019.
Seattle-based F5 Networks beat expectations for its most recent fiscal quarter as it continues to expand beyond its traditional networking hardware business into software and services. Seattle-based Nautilus Biotechnology appointed Human Protein Atlas Director Emma Lundberg to its scientific advisory board. Chris Bright.
The initial focus for the accelerator will be the burgeoning sector of computational health, or the intersection of healthcare and software, two strengths of Seattle’s tech ecosystem. Computational health: Seattle has emerged as a global hub for companies that are combining software such as machine learning and AI with healthcare.
Scientists are using software to design new biomolecules that treat cancer and block viral infection. Photo by Ian Haydon, UW Medicine Institute for Protein Design.). The speed of the creation of vaccines for the SARS-CoV-2 virus that causes COVID-19 was a modern marvel. Eric Horvitz, Microsoft chief scientific officer. Microsoft Photo).
Francis Lo, chief people officer at Adaptive Biotechnologies, accepts the Workplace of the Year Award at the 2023 GeekWire Awards. Five startups building everything from a real estate platform to software that recommends what TV shows to watch are also building cultures aimed at keeping employees satisfied. Satisfaction.
Phase Genomics has developed technology for sequencing DNA from wide-ranging and tricky to study organisms. Other former positions include leadership roles at the Gates Foundation and directing the global drug development program at PATH. Susan Wyrick of Sana Biotechnology.
The majority operate in enterprise software or cloud computing. In fact, GeekWire reported this week on a little-known enterprise software company that just joined the unicorn ranks. Co-founder and CEO : Manny Medina , former director of business development at Microsoft. Sana Biotechnology. Valuation : $1.3 Sana Photo).
. — Microsoft added to its senior leadership team with the appointment of Christopher Young as executive vice president of business development. Young will be responsible for developing Microsoft’s global business development strategies, including assessing partnerships, alliances, venture investments, and joint ventures.
On March 21, CEO Jensen Huang (pictured) told attendees at the company’s online-only developer conference, GTC 2023, about a string of new services Nvidia hopes enterprises will use to train and run their own generative AI models. It named biotechnology company Amgen as one of the first users of the service.
And then today, another blockbuster unicorn boosted its valuation, with Seattle-based sales engagement software company Highspot raising $248 million at a $3.5 Of the 15 companies on the list, nine of the companies employ CEOs who spent time at the software giant, many in high-level executive roles. billion valuation. Founded : 2013.
(Vouched Photo) — Peter Horadan , a seasoned Seattle tech executive who was an executive at Avalara and later founded an accounting software startup called Lockstep, joined identity verification startup Vouched as its new CEO. Sana Photo) — Dhaval Patel joined Sana Biotechnology as executive vice president and chief scientific officer.
The five finalists for the Health Innovation of the Year at the GeekWire Awards highlight the multitude of ways that technology is changing healthcare, from treatment in the hospital to the development of new therapeutics. Read more about the finalists and cast your vote below. Read more about the finalists and cast your vote below.
From left: Cyrus Biotechnology CEO Lucas Nivon, Microsoft researcher Jonathan Carlson, Deepcell CEO Maddison Masaeli, and moderator Chris Picardo, a Madrona venture partner. ” Protein rings hallucinated by AI-powered software from the UW’s Institute for Protein Design. GeekWire Photo / Charlotte Schubert). IPD Image).
— Maureen Ezekwugo is now CEO of Oggvo , which develops customer review management software for small- to medium-sized businesses. She is also a board member of Ada Developers Academy, a Seattle nonprofit. Maureen Ezekwugo. Oggvo Photo). Director of Sales Jerome Byrd , previously a commercial leader at NuVasive.
based enterprise software company EnterpriseDB (EDB). Dallas spent almost 25 years at Microsoft, most recently as vice president of cloud and artificial intelligence business development. Founded in 2004, the company makes software to help enterprises use Postgres, an open-source database. billion acquisition by Aptiv in 2022.
We organize all of the trending information in your field so you don't have to. Join 83,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content